Metastatic Potential of T1 Breast Cancer Can Be Predicted by the 70-gene MammaPrint Signature

PUBLICATION: Ann Surg Oncol. 2010 May;17(5):1406-13. doi: 10.1245/s10434-009-0902-x. Epub 2010 Read More

2024-03-25T11:00:58-04:00May 1st, 2010|Adjuvant, Evidence, MammaPrint|

The 70-gene Signature as a Response Predictor for Neoadjuvant Chemotherapy in Breast Cancer

PUBLICATION: Breast Cancer Res Treat. 2010 Feb;119(3):551-8. doi: 10.1007/s10549-009-0333-1. Epub Read More

2024-03-25T11:03:35-04:00February 1st, 2010|Evidence, MammaPrint, Neoadjuvant|

The 70-gene Prognosis Signature Predicts Early Metastasis in Breast Cancer Patients Between 55 and 70 Years of Age

PUBLICATION: Ann Oncol. 2010 Apr;21(4):717-22. doi: 10.1093/annonc/mdp388. Epub 2009 Oct Read More

2024-03-25T11:06:57-04:00October 13th, 2009|Adjuvant, Evidence, MammaPrint|

Gene Expression Profiling in Breast Cancer โ€“ Design of a Pooled Database to Address Open Questions

PUBLICATION: Eur Surg (2009) 41: 221. https://doi.org/10.1007/s10353-009-0487-4. AUTHORS: M. Knauer, Read More

2024-03-25T11:07:44-04:00October 1st, 2009|Evidence, MammaPrint, Other|

A Gene Expression Profile for Detection of Sufficient Tumour Cells in Breast Tumour Tissue: Microarray Diagnosis Eligibility

PUBLICATION: BMC Med Genomics. 2009 Aug 12;2:52. doi: 10.1186/1755-8794-2-52. AUTHORS: Read More

2024-03-25T11:08:30-04:00August 1st, 2009|Evidence, MammaPrint, Other|

The 70-gene Prognosis-Signature Predicts Disease Outcome in Breast Cancer Patients with 1-3 Positive Lymph Nodes in an Independent Validation Study

PUBLICATION: Breast Cancer Res Treat. 2009 Jul;116(2):295-302. doi: 10.1007/s10549-008-0130-2. Epub Read More

2024-03-25T11:09:15-04:00July 27th, 2009|Evidence, MammaPrint, Other, Validation|

Daily Clinical Practice of Fresh Tumour Tissue Freezing and Gene Expression Profiling; Logistics Pilot Study Preceding the MINDACT Trial

PUBLICATION: Eur J Cancer. 2009 May;45(7):1201-1208. doi: 10.1016/j.ejca.2009.01.004. Epub 2009 Read More

2024-03-25T11:09:51-04:00May 1st, 2009|Evidence, MammaPrint, Other|

Constructive Technology Assessment (CTA) as a Tool in Coverage with Evidence Development: The Case of the 70-gene Prognosis Signature for Breast Cancer Diagnostics

PUBLICATION: Int J Technol Assess Health Care. 2009 Jan;25(1):73-83. doi: Read More

2024-03-25T11:11:06-04:00January 24th, 2009|Evidence, MammaPrint, Other|
Go to Top